View Post

Breast cancer drug in first human clinical trial

In Clinical Trials by Barbara Jacoby

By: Jacqueline Carey, University of Illinois at Chicago From: medicalxpress.com A University of Illinois at Chicago-developed breast cancer drug that has the potential to help women whose cancer has stopped responding to hormone therapy recently entered its first human clinical trial. Breast cancer affects one in eight women in the United States, and while there are many types of breast …

View Post

Scientists develop system to rapidly and accurately detect tumor margins during breast cancer surgery

In Clinical Trials by Barbara Jacoby

From: medicalxpress.com Scientists from the RIKEN Cluster for Pioneering Research (CPR), Osaka University, and collaborators have developed a new rapid and inexpensive way to accurately detect the margins between cancer and non-cancerous tissue during breast surgery. Their system is noteworthy in that it can detect the morphology of the cells, differentiating between cells that are more or less dangerous. Today, …

View Post

How prior authorization hobbles breast cancer care

In In The News by Barbara Jacoby

Source: American Medical Association Staff Writer From: ama-assn.org A study examining the work required to meet prior-authorization (PA) requirements for breast cancer medications points to significant staff time lost securing permission for covered use. The drugs were nearly always approved as medically necessary. Researchers examined the processing steps and progress of prior-authorization requests covering 324 prescriptions for 279 breast cancer …

View Post

Multiple Oncotype DX Study Presentations at the 2018 San Antonio Breast Cancer Symposium Reinforce Real-world Value of the Oncotype DX Breast Recurrence Score® Test in Patients Regardless of Age or Race

In Clinical Trials by Barbara Jacoby

News provided by: WCG/Genomic Health From: prnewswire.com Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple Oncotype DX Breast Recurrence Score® (RS) presentations at the 2018 San Antonio Breast Cancer Symposium® (SABCS), reinforcing the value of the Oncotype DX® test in optimizing treatment and outcomes in patients with both node-negative and node-positive early-stage breast cancer. Among the data presented …

View Post

Research From Scottsdale Radiation Oncologist, Dr. Robert Kuske, Presents Important Data in Stage 0,1, or 2 Breast Cancer

In In The News by Barbara Jacoby

Source: Arizona Breast Cancer Specialists From: prnewswire.com Research from one of Scottsdale-based Arizona Breast Cancer Specialists‘ founders (a division of Arizona Center for Cancer Care), Robert Kuske, MD, was presented at the 2018 San Antonio Breast Cancer Symposium held December 4-8. The data suggests that a 5-day course of radiation treatment known as Partial Breast Irradiation (PBI) may be an …

View Post

Collaboration Promises Better, More Accurate Breast Cancer Diagnostics

In In The News by Barbara Jacoby

From: PR Newswire Data-sharing result s in an improved method of HER2 protein analysis which promises more accurate breast cancer diagnosis results. The Health Exchange Market, or T.H.E.M.™, together with LabCorp, Konica Minolta, Inc. University of Rochester, Penn State Hershey Medical Center and Lebanon VA Medical Center, has presented significant findings in breast cancer research at the 2018 San Antonio …

View Post

12 myths about cancer, debunked

In In The News by Barbara Jacoby

Presented by Cancer Treatment Centers of America From: tulsaworld.com When it comes to cancer, there are many myths that get passed around by well-meaning friends and family members. Those myths can end up causing more stress for patients than they were already experiencing. Because understanding your diagnosis is an essential part of moving forward with your treatment plan, here are …